Walk-in Interview for Multiple Positions at Umedica Laboratories Pvt Ltd for B. Pharma/ M. Pharma/ B. Sc./ M. Sc/ ITI/ Diploma – 23 April 2023

UMEDICA is a part of the Amoli Group of Companies, manufacturing and exporting a wide range of formulations viz; Injectables, Tablets, Capsules, Suspensions, Dry Syrups, etc. UMEDICA offers a diverse product portfolio with a patient-centric approach comprising of antibiotics, anti-diabetics,…

Walk-in Interview for B. Pharma/ M. Pharma/ B. Sc./ M. Sc./ Diploma/ ITI for Multiple Positions at Granules India Ltd – 22 April 2023

Granules India is a vertically integrated, high-growth pharmaceutical company with 38 years of proven performance and increasing presence across the world. Headquartered in Hyderabad, India, Granules offers collaborative and strategic partnership to global pharmaceutical leaders by producing best quality API,…

In persons with certain forms of adjuvant liver cancer, Roche reports that the Tecentriq + Avastin phase III IMbrave050 research lowers the likelihood of the cancer coming back.

Avastin (bevacizumab) plus Tecentriq (atezolizumab) showed a statistically significant improvement in recurrence-free survival (RFS) in patients with hepatocellular carcinoma (HCC) at high risk of disease recurrence following liver resection or ablation with the intention of curing the disease, according to…

Back to top

Registration Form


This will close in 0 seconds

WhatsApp Join Telegram